Shields, A, Faustini, SE, Perez-Toledo, M, Jossi, S, Aldera, E, Allen, JD, Al-Taei, S, Backhouse, C, Bosworth, A, Dunbar, LA, Ebanks, D, Emmanuel, B, Garvey, M, Gray, J, Kidd, IM, McGinnell, G, McLoughlin, DE, Morley, G, O'Neill, J, Papakonstantinou, D, Pickles, O, Poxon, C, Richter, M, Walker, EM, Wanigasooriya, K, Watanabe, Y, Whalley, C, Zielinska, AE, Crispin, M, Wraith, DC, Beggs, AD, Cunningham, AF, Drayson, MT and Richter, AG (2020) SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax, 75 (12). 1089 - 1094. ISSN 0040-6376

[thumbnail of 1089.full.pdf]
1089.full.pdf - Published Version

Download (337kB) | Preview


<jats:sec><jats:title>Objective</jats:title><jats:p>To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms consistent with COVID-19. No potential participants were excluded.</jats:p></jats:sec><jats:sec><jats:title>Intervention</jats:title><jats:p>Participants volunteered a nasopharyngeal swab and a venous blood sample that were tested for SARS-CoV-2 RNA and anti-SARS-CoV-2 spike glycoprotein antibodies, respectively. Results were interpreted in the context of prior illnesses and the hospital departments in which participants worked.</jats:p></jats:sec><jats:sec><jats:title>Main outcome measure</jats:title><jats:p>Proportion of participants demonstrating infection and positive SARS-CoV-2 serology.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The point prevalence of SARS-CoV-2 viral carriage was 2.4% (n=13/545). The overall seroprevalence of SARS-CoV-2 antibodies was 24.4% (n=126/516). Participants who reported prior symptomatic illness had higher seroprevalence (37.5% vs 17.1%, χ<jats:sup>2</jats:sup>=21.1034, p&lt;0.0001) and quantitatively greater antibody responses than those who had remained asymptomatic. Seroprevalence was greatest among those working in housekeeping (34.5%), acute medicine (33.3%) and general internal medicine (30.3%), with lower rates observed in participants working in intensive care (14.8%). BAME (Black, Asian and minority ethnic) ethnicity was associated with a significantly increased risk of seropositivity (OR: 1.92, 95% CI 1.14 to 3.23, p=0.01). Working on the intensive care unit was associated with a significantly lower risk of seropositivity compared with working in other areas of the hospital (OR: 0.28, 95% CI 0.09 to 0.78, p=0.02).</jats:p></jats:sec><jats:sec><jats:title>Conclusions and relevance</jats:title><jats:p>We identify differences in the occupational risk of exposure to SARS-CoV-2 between hospital departments and confirm asymptomatic seroconversion occurs in healthcare workers. Further investigation of these observations is required to inform future infection control and occupational health practices.</jats:p></jats:sec>

Item Type: Article
Additional Information: This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See:
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Depositing User: Symplectic
Date Deposited: 23 Feb 2023 12:13
Last Modified: 23 Feb 2023 12:13

Actions (login required)

View Item
View Item